208 related articles for article (PubMed ID: 15384161)
1. Clinical proteomics: a question of technology.
Kolch W; Mischak H; Chalmers MJ; Pitt A; Marshall AG
Rapid Commun Mass Spectrom; 2004; 18(19):2365-6. PubMed ID: 15384161
[No Abstract] [Full Text] [Related]
2. Proteomics: evolution of the technology.
Patterson SD
Biotechniques; 2003 Sep; 35(3):440-4. PubMed ID: 14513544
[No Abstract] [Full Text] [Related]
3. Mass spectrometry-based proteomics in reproductive medicine.
Kolialexi A; Mavrou A; Spyrou G; Tsangaris GT
Mass Spectrom Rev; 2008; 27(6):624-34. PubMed ID: 18618655
[TBL] [Abstract][Full Text] [Related]
4. Applying proteomics technology to platelet research.
García A; Watson SP; Dwek RA; Zitzmann N
Mass Spectrom Rev; 2005; 24(6):918-30. PubMed ID: 15599945
[TBL] [Abstract][Full Text] [Related]
5. Developments in quantitative mass spectrometry for the analysis of proteome dynamics.
Hughes C; Krijgsveld J
Trends Biotechnol; 2012 Dec; 30(12):668-76. PubMed ID: 23107010
[TBL] [Abstract][Full Text] [Related]
6. Valid data from large-scale proteomics studies.
Chamrad D; Meyer HE
Nat Methods; 2005 Sep; 2(9):647-8. PubMed ID: 16118632
[No Abstract] [Full Text] [Related]
7. Proteome analysis in the study of lymphoma cells.
Joubert-Caron R; Caron M
Mass Spectrom Rev; 2005; 24(4):455-68. PubMed ID: 15389845
[TBL] [Abstract][Full Text] [Related]
8. How do shotgun proteomics algorithms identify proteins?
Marcotte EM
Nat Biotechnol; 2007 Jul; 25(7):755-7. PubMed ID: 17621303
[No Abstract] [Full Text] [Related]
9. Separation technologies. Supporting solutions.
Lederman L
Biotechniques; 2004 Nov; 37(5):716-7. PubMed ID: 15560123
[No Abstract] [Full Text] [Related]
10. Analyzing proteomic expression in a clinical screening environment using mass spectrometry.
Chace DH; Spitzer A
Expert Rev Proteomics; 2005 Aug; 2(4):453-4. PubMed ID: 16097879
[No Abstract] [Full Text] [Related]
11. Mass spectrometry-based quantitative proteomics.
Heck AJ; Krijgsveld J
Expert Rev Proteomics; 2004 Oct; 1(3):317-26. PubMed ID: 15966828
[TBL] [Abstract][Full Text] [Related]
12. Opportunities for nanotechnology-based innovation in tissue proteomics.
Geho DH; Lahar N; Ferrari M; Petricoin EF; Liotta LA
Biomed Microdevices; 2004 Sep; 6(3):231-9. PubMed ID: 15377833
[TBL] [Abstract][Full Text] [Related]
13. Review of a current role of mass spectrometry for proteome research.
Chen CH
Anal Chim Acta; 2008 Aug; 624(1):16-36. PubMed ID: 18706308
[TBL] [Abstract][Full Text] [Related]
14. Analytical aspects of proteomics: 2009-2010.
Ning Z; Zhou H; Wang F; Abu-Farha M; Figeys D
Anal Chem; 2011 Jun; 83(12):4407-26. PubMed ID: 21491952
[No Abstract] [Full Text] [Related]
15. [Multiplexed analysis for identification and evaluation of novel biomarkers in biological fluids, tissue and cell extracts].
Lehmann S; Dupuy A; Beaudeux JL; Lizard G
Ann Biol Clin (Paris); 2009; 67(4):381-93. PubMed ID: 19654078
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry: uncovering the cancer proteome for diagnostics.
van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
[TBL] [Abstract][Full Text] [Related]
17. Serum proteomics profiling--a young technology begins to mature.
Coombes KR; Morris JS; Hu J; Edmonson SR; Baggerly KA
Nat Biotechnol; 2005 Mar; 23(3):291-2. PubMed ID: 15765078
[No Abstract] [Full Text] [Related]
18. Quantitative proteomics: the next logical step in molecular phenotyping.
Veenstra TD; Blonder J
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):89. PubMed ID: 19398504
[No Abstract] [Full Text] [Related]
19. Proteomics in neurosciences.
Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
[TBL] [Abstract][Full Text] [Related]
20. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
